Patents for C07C 233 - Carboxylic acid amides (28,881) |
---|
02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
02/14/2006 | CA2245197C Unsaturated derivatives in position -4 of 6-tert-butyl-1, 1-dimethylindan and their use in human or veterinary medicine and in cosmetics |
02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
02/09/2006 | US20060030553 Cell adhesion inhibitors |
02/09/2006 | CA2573223A1 Aromatic compound |
02/08/2006 | EP1623972A1 Solid n-acylalanine or salts thereof |
02/08/2006 | EP1406865B1 Succinic acid derivatives |
02/08/2006 | EP1144348B1 Lta 4 hydrolase inhibitors |
02/08/2006 | EP1117634B1 Dialkyl quaternary ammonium derivatives of oils, fatty acids, triglycerides and their use in personal care products |
02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
02/08/2006 | CN1732156A Biphenyl derivatives and their use as fungicides |
02/08/2006 | CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
02/08/2006 | CN1240672C Process for producing acidic N(long-chain acyl) amino acid |
02/07/2006 | US6995285 ABCA-1 elevating compounds |
02/07/2006 | US6995284 Synthesis of selective androgen receptor modulators |
02/07/2006 | US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group |
02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
02/02/2006 | WO2006012227A2 Amido compounds and their use as pharmaceuticals |
02/02/2006 | WO2006011669A1 Novel cinnamic acid related compounds |
02/02/2006 | WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
02/02/2006 | WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators |
02/02/2006 | WO2006010362A1 Amino adamantane derivatives, methods for the production and use thereof |
02/02/2006 | US20060025630 Synthesis on N-vinyl formamide |
02/02/2006 | US20060025594 Small molecule entry inhibitors |
02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
02/02/2006 | US20060025472 Fungicidal carboxamides |
02/02/2006 | US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
02/02/2006 | CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators |
02/02/2006 | CA2570694A1 Amido compounds and their use as pharmaceuticals |
02/01/2006 | EP1620391A2 Cyclic derivatives as modulators of chemokine receptor activity |
02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/01/2006 | CN1239572C Polyalkoxylated superamides optionally functionalised, use as emulsifiers |
02/01/2006 | CN1239495C Fungicides for control of take-all disease of plants |
02/01/2006 | CN1239469C Chiral amine compound and its synthesis and use |
01/31/2006 | US6992220 useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C. |
01/31/2006 | US6992219 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; treatment of sleep disorders |
01/31/2006 | US6992207 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
01/31/2006 | CA2119261C Novel sidechain-bearing taxanes and intermediates thereof |
01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
01/26/2006 | WO2006010094A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
01/26/2006 | WO2006009320A1 Process for production of powdery n-(long-chain acyl)- amino acids or salts thereof, powdery n-(long-chain acyl)amino acids or salts thereof, and facial cleansing powders |
01/26/2006 | WO2006007957A1 Process for preparing monomers and polymers thereof |
01/26/2006 | WO2005108409A3 Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts |
01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
01/26/2006 | US20060020003 Biphenyloxy-acids |
01/26/2006 | DE19612432B4 Verfahren zum Entfernen eines unlöslichen N-Vinylamidpolymers aus einer Anlage A method for removing an insoluble N-Vinylamidpolymers from a plant |
01/26/2006 | DE102004030616A1 Verfahren zur Reinigung von Dimethylacetamid (DMAc) A process for the purification of dimethylacetamide (DMAc) |
01/26/2006 | CA2573627A1 Process for preparing monomers and polymers using rhodococcus genus |
01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
01/26/2006 | CA2573128A1 Preparation of beta-amino acids having affinity for the alpha-2-delta protein |
01/26/2006 | CA2572775A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
01/26/2006 | CA2513080A1 Inhibitors of the anandamide transporter |
01/25/2006 | EP1618087A2 Antibacterial agents |
01/25/2006 | EP1617803A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
01/25/2006 | EP1097158B1 Ligands for metals and metal-catalyzed processes |
01/25/2006 | CN1726185A Formulations comprising selective androgen receptor modulators and using method thereof |
01/25/2006 | CN1724511A Method of extracting capsaicin and capsaithin from red pepper |
01/25/2006 | CN1724507A Optically pure alpha-difluoromethylamine and method of highly stereo-seective preparation |
01/24/2006 | US6989461 Containing a transition metal compound selected from ruthenium and rhodium, a chiral ligand containing a cyclic (R'R"NP)-(O-R-O-) group |
01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
01/19/2006 | CA2573243A1 Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives |
01/18/2006 | EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes |
01/18/2006 | EP1615880A2 Preparation and purification of synthetic capsaicin |
01/18/2006 | EP1615876A1 Method for the purification of dimethylacetamide (dmac) |
01/18/2006 | EP0973727B8 Activated iododerivatives for the treatment of cancer and aids |
01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
01/18/2006 | CN1723192A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
01/18/2006 | CN1723191A Vermin-repellant compositions and compounds |
01/18/2006 | CN1723190A Polymorphic forms of nateglinide |
01/18/2006 | CN1721392A Process for preparing N,N-dimethyl chloroacetamide |
01/17/2006 | US6987084 Photo-labile pro-fragrance conjugates |
01/17/2006 | CA2172014C Preparation of .alpha.-chloroalkyl aryl ketones |
01/12/2006 | WO2006003923A1 Substituted benzene compound |
01/12/2006 | WO2006003194A1 Process for preparing amines and a carboxamide thereof |
01/12/2006 | US20060009488 Prodrugs of selective androgen receptor modulators and methods of use thereof |
01/12/2006 | US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
01/12/2006 | US20060009476 Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof |
01/12/2006 | CA2566648A1 Guanylhydrazone salts, compositions, processes of making and methods of using |
01/11/2006 | EP1613589A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
01/11/2006 | EP0956318B1 Radiation-curable composition |
01/11/2006 | CN1720252A Transition metal complex having diphosphine complex as ligand |
01/11/2006 | CN1236000C Electronic donor compound capable of solidifying |
01/11/2006 | CN1235887C Preparation method of xazolyl alcohol derivatives |
01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
01/10/2006 | US6984755 reacting ethylene, carbon monoxide, and propanoic acid in presence of catalyst containing bidentate phosphate ligand |
01/10/2006 | US6984715 for production of polyurethane coatings; abrasion/solvent/weather resistance |
01/10/2006 | US6984664 Reduce side effect; analgesics |
01/10/2006 | US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes |
01/05/2006 | WO2006002361A2 2-methylpropanamides and their use as pharmaceuticals |
01/05/2006 | WO2006000392A1 Method for the purification of dimethylacetamide (dmac) |
01/05/2006 | WO2006000324A2 New mao-b inhibitors |
01/05/2006 | WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
01/05/2006 | US20060004103 Method for producing lysine derivative |
01/05/2006 | US20060004102 Crystal structure; comminution in solvent; crystallization; antidiabetic agents |